Search Results - "Zagozdzon, R"

Refine Results
  1. 1

    Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients by Bujnowska, A., Michon, M., Konopelski, P., Hryniewiecka, E., Jalbrzykowska, A., Perkowska-Ptasinska, A., Cieciura, T., Zagozdzon, R., Paczek, L., Ciszek, M.

    Published in Transplantation proceedings (01-07-2018)
    “…Treatment of antibody-mediated rejection (AMR) is one of the main problems after kidney transplantation (KTx). The results of intensive AMR treatment with…”
    Get full text
    Journal Article
  2. 2
  3. 3

    NRP B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors by Seng, S, Avraham, H K, Birrane, G, Jiang, S, Li, H, Katz, G, Bass, C E, Zagozdzon, R, Avraham, S

    Published in Oncogene (22-01-2009)
    “…Brain tumors are associated with genetic alterations of oncogenes and tumor suppressor genes. Accumulation of reactive oxygen species (ROS) in cells leads to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice by Feleszko, W., Zagożdżon, R., Gołąb, J., Jakóbisiak, M.

    Published in European journal of cancer (1990) (01-02-1998)
    “…Lovastatin, the drug used in the treatment of hypercholesterolaemia, has previously been reported to exert synergistic antitumour activity in a melanoma model…”
    Get full text
    Journal Article
  6. 6

    Immunomodulation by anticancer chemotherapy: more is not always better (review) by Zagozdzon, R, Golab, J

    Published in International journal of oncology (01-02-2001)
    “…Chemotherapeutics are the mainstay of the majority of antitumor treatment strategies. These agents are usually administered at or near maximum tolerated doses…”
    Get more information
    Journal Article
  7. 7

    Reversal of stage 5 chronic kidney disease by aortic valve replacement in kidney transplant recipient: a case report by Hryniewiecka, E, Hryniewiecki, T, Różański, J, Pilecki, T, Zagożdżon, R, Orłowski, T, Gołębiowski, M, Pączek, L, Mucha, K, Foroncewicz, B

    Published in BMC cardiovascular disorders (17-01-2020)
    “…Cardiorenal syndrome (CRS) is a group of pathophysiological disorders affecting heart and kidneys. We present 44-year-old kidney transplant recipient with…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression by Lachota, Mieszko, Lennikov, Anton, Malmberg, Karl-Johan, Zagozdzon, Radoslaw

    Published in Journal of immunology research (2021)
    “…Tumor-infiltrating immune cells are capable of effective cancer surveillance, and their abundance is linked to better prognosis in numerous tumor types…”
    Get full text
    Journal Article
  12. 12

    Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo by Zagozdzon, R, Golab, J, Mucha, K, Foroncewicz, B, Jakobisiak, M

    “…The early clinical trials with interleukin-12 (IL-12) have demonstrated substantial toxicity of this cytokine. One way to resolve this problem would be to find…”
    Get more information
    Journal Article
  13. 13

    Prospects for NK Cell Therapy of Sarcoma by Lachota, Mieszko, Vincenti, Marianna, Winiarska, Magdalena, Boye, Kjetil, Zagożdżon, Radosław, Malmberg, Karl-Johan

    Published in Cancers (11-12-2020)
    “…Natural killer (NK) cells are innate lymphoid cells with potent antitumor activity. One of the most NK cell cytotoxicity-sensitive tumor types is sarcoma, an…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation by Lachota, Mieszko, Zielniok, Katarzyna, Palacios, Daniel, Kanaya, Minoru, Peena, Leena, Hoel, Hanna Julie, Wiiger, Merete Thune, Kveberg, Lise, Hautz, Wojciech, Zagożdżon, Radosław, Malmberg, Karl-Johan

    Published in EBioMedicine (01-10-2023)
    “…Natural killer (NK) cells have a unique capability of spontaneous cytotoxicity against malignant cells and hold promise for off-the-shelf cell therapy against…”
    Get full text
    Journal Article
  17. 17

    Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome by Wójcik, C, Stoklosa, T, Giermasz, A, Golab, J, Zagozdzon, R, Kawiak, J, Wilk, S, Komar, A, Kaca, A, Malejczyk, J, Jakóbisiak, M

    Published in Apoptosis (London) (1997)
    “…Of a number of factors involved in apoptosis, protease activity may play a crucial role. We show that N-benzyloxycarbonyl-Ile-Glu( O-t-butyl)-Ala-leucinal…”
    Get full text
    Journal Article
  18. 18

    Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF by GOLAB, J, WILCZYNSKI, G, KAMINSKI, R, GIERMASZ, A, CZAJKA, A, LASEK, W, FELESZKO, W, JAKOBISIAK, M, ZAGOZDZON, R, STOKLOSA, T, DABROWSKA, A, RYBCZYNSKA, J, WASIK, M, MACHAJ, E, OLDAK, T, KOZAR, K

    Published in British journal of cancer (01-04-2000)
    “…Photofrin-based photodynamic therapy (PDT) has recently been approved for palliative and curative purposes in cancer patients. It has been demonstrated that…”
    Get full text
    Journal Article
  19. 19

    Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in mice by Gołab, J, Zagozdzon, R, Stokłosa, T, Kaca, A, Dabrowska, A, Giermasz, A, Feleszko, W, Jakóbisiak, M

    Published in Neoplasma (1998)
    “…Granulocyte colony-stimulating factor (G-CSF) was found to exert antitumor activity against murine MmB16 melanoma when administered intratumorally. However,…”
    Get full text
    Journal Article
  20. 20